Fight over where to house ARPA-H still brews with House bill's passage
The Biden administration isn’t backing down from its desire to keep a new drug accelerator, known as ARPA-H, inside the National Institutes of Health.
But the House on Wednesday passed a bill by an overwhelming bipartisan majority (336 to 85) to make this new accelerator a standalone agency.
Anna Eshoo (D-CA), the author of the House bill, made clear that the separation from NIH is intentional, saying in a statement that “the House passed my ARPA-H legislation to create a new agency with the authorities and autonomy it needs to be successful and ensuring it will be a nimble, dynamic, and independent agency.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.